Neuro-Bio is delighted to welcome Helen Collins as Senior Scientist. Helen received her DPhil in Neuroscience from the University of Oxford in 2023. She developed a mouse model of Antidepressant Discontinuation Syndrome, with which she investigated changes in serotonergic signalling using in vivo and ex vivo approaches. Previously, she graduated with an BA in Cell and Systems Biology and a MSc in Neuroscience from the University of Oxford, having gained experience in preclinical studies of neurodegeneration. Helen joins Neuro-Bio as a Senior Scientist to investigate the cellular mechanisms of Alzheimer’s disease in primary neuronal cultures and to develop a novel mouse model of the condition.
LATEST NEWS
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!
- Our CSO Sara Garcia Rates & Project Development Manager, Bethany Watkinson, will be attending the MediWales (BioWales) event on Thursday 5th February
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield is attending the “Inspire and Innovate with wise+ (Women in Innovation, Science & Engineering)” at the Novartis Basel Campus